本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Scpharmaceuticals Inc.

5.67
0.0000
成交量:- -
成交額:6,179.38萬
市值:3.04億
市盈率:-3.21
高:5.67
開:5.67
低:5.67
收:5.67
52周最高:6.28
52周最低:1.94
股本:5,367.88萬
流通股本:3,253.65萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.7677
每股收益(LYR):-1.9126
淨資產收益率:-934.02%
總資產收益率:-57.08%
市淨率:-14.28
市盈率(LYR):-2.96

資料載入中...

2025/03/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/19

重要事件披露

Form 8-K - Current report
2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/31

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/12/11

重要事件披露

Form 8-K - Current report
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/10/30

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/15

重要事件披露

Form 8-K - Current report
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/12

重要事件披露

Form 8-K - Current report
2024/07/03

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/20

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals